Source
Peptides are synthesised at GMP-equivalent facilities. Each lot ships with its own original Certificate of Analysis as the starting paperwork — never a pooled or generic document.
About TogoPeptide
A focused supply chain — from a sealed NL warehouse to the bench — built around one rule: every vial ships with its own Certificate of Analysis, or it does not ship.
The story
Why we exist. The research-grade peptide supply chain in Europe has historically been fragmented. Most labs and independent researchers face the same trio of problems: opaque sourcing, generic supplier guarantees instead of per-batch analysis, and cold-chain handling that breaks somewhere between synthesis and the parcel desk. The result is material that arrives without paperwork, often without identity confirmation, sometimes without potency. That is not acceptable for any work that calls itself research.
What we built. TogoPeptide is a tightly-scoped, EU-stocked research-peptide supplier operating from Cuijk, Netherlands. Every compound is synthesised at GMP-equivalent facilities, independently re-tested by HPLC and mass-spectrometry on its own batch, lyophilised, sealed, and held at −20°C in our own warehouse. Each parcel ships with the signed COA for the exact batch in the box. No pooled certificates. No "representative" data. No catalog bloat.
What we believe. Transparency over hype. Research-frame language over health claims. Per-batch verification over generic supplier guarantees. We hold a hard line: we supply researchers, not patients. Every product page, every checkout, every email reflects that line — because the moment you start writing dosing tables and outcome promises, you have stopped being a research supplier.
Founder
Founder & Operator
Cuijk, Netherlands · founder, TNF Business (KvK 89971418)
Empire-building entrepreneur with a focus on EU-grade research supply chains. Operates TogoPeptide as a venture under TNF Business alongside other independent projects. Not a clinician, not a researcher — an operator who chose to spend obsessive attention on a supply problem most suppliers ignore: per-batch verification, cold-chain integrity, and the discipline to refuse medical positioning.
The process
A short, deliberate chain — with a verification gate at every link.
Peptides are synthesised at GMP-equivalent facilities. Each lot ships with its own original Certificate of Analysis as the starting paperwork — never a pooled or generic document.
Independent HPLC plus mass-spectrometry on every batch. The internal acceptance bar is ≥98% target purity with confirmed identity — lots that miss the bar do not enter inventory.
Lyophilised, vacuum-sealed, and held at −20°C in the Cuijk warehouse until the moment a parcel is built. No long shelf-time degradation; no warm-cycle exposure.
Discreet, neutral packaging. EU-only delivery. The signed per-batch COA is included physically inside the parcel — not just emailed — so the paperwork travels with the material.
Timeline
A short history — deliberate, public, and still being written.
2024
Holding entity registered at Grotestraat 46, Cuijk — KvK 89971418. The umbrella for TogoPeptide and other ventures.
2025
First catalog goes live at togopeptide.com with the per-batch COA model and EU cold-chain warehousing.
2026
49 research compounds across seven categories, six curated stacks live, 30+ pillar articles in the research library, full 10-language i18n hand-crafted (no machine-translation).
Next
Mollie live-mode payments after TNF KYC clears. Expanded EU shipping zones. Deeper compound deep-dives in the research library. More transparency, never less.
Values
Research-grade. Transparent. Sustainable. The discipline behind every decision.
Never marketed as therapy. Lyophilised material is supplied strictly for laboratory research purposes only. No dosing tables, no protocols, no health-outcome promises. Ever. The site — and our messaging — will never read like a pharmacy.
Per-batch COA in every parcel. HPLC + mass-spec data, lab-verified purity, identifiable sourcing path, public terms and shipping policies. Read a sample COA or our full quality standard.
EU-local supply chain — no transatlantic shuttling. Neutral, recyclable shipping materials. Cold packs reused where logistically sound. Catalog discipline (no bloat) is itself a sustainability decision: we do not stock what we cannot move fresh.
Why Netherlands
The home country is a deliberate choice — not a default.
The Netherlands gives a research-supply operation three things that are difficult to assemble elsewhere on the continent: a workable customs posture for laboratory-use materials, a dense logistics grid that touches every other EU member within 24–48 hours, and a mature financial layer (iDEAL, SEPA, Bancontact) that lets European researchers pay in their own rails without bouncing through a US processor.
Operating from Cuijk — a small city in Noord-Brabant near the German border — means the warehouse sits inside the EU customs union. There is no transatlantic shuttle, no warm-cycle exposure during long-haul transit, and no surprise import duty on the buyer's side. EU in, EU out.
The legal home is TNF Business B.V., registered with the Dutch Chamber of Commerce as KvK 89971418. That registration is public, the address is public, and the entity behind the brand is the same entity that signs the COA — not a shell, not a marketplace tenant.
Research-grade, defined
The phrase is used loosely across the industry. We use it narrowly — and we hold ourselves to the narrow reading.
Material standard. Every lot is synthesised at a GMP-equivalent facility, characterised by independent HPLC for purity and by mass-spectrometry for identity, and held to a written acceptance bar of ≥98% target purity. Lots that miss the bar do not enter inventory — not at a discount, not in a clearance bin.
Paperwork standard. The Certificate of Analysis is per-batch, never pooled. It carries the lot code that is printed on the vial, the date the assay was run, the laboratory that ran it, and the numerical result. A signed copy ships physically inside the parcel; an emailed copy follows. The same lot code resolves on the public COA library.
Positioning standard. The site — and our messaging — will never read like a pharmacy. No dosing tables, no “protocols”, no health-outcome claims, no before-and-after photography, no testimonials describing personal use. Material is sold strictly for laboratory research purposes, and that line is held in copy, in product pages, in support email, and in this paragraph.
What this excludes. We do not supply human-grade injectables, we do not certify for clinical use, and we do not sell quantities or formats designed for in-vivo human research without a corresponding institutional protocol. Read the full research-use disclaimer for the legal frame.
We supply researchers, not patients. Every vial is a tool — verifiable, traceable, and never positioned as medicine. That is the line we hold.
Where to next
Catalog
49 compounds across seven research categories. Each with its own page, batch history, and reconstitution notes.
Open the shop →Library
30+ peer-reviewed pillar articles — mechanism deep-dives, comparison studies, methodology notes.
Enter the hub →